FLGR242 (5mg) x2 Vials **PRESALE**

All orders will be shipped in January

• Composition and format
FLGR242 is a synthetic peptide analog supplied as a 10 mg lyophilized powder in a single vial. The batch-specific Certificate of Analysis (COA) provides sequence confirmation and formulation details to support method-level reproducibility and documentation control.

• Analytical verification
Each lot is qualified at 99%+ purity by high-performance liquid chromatography; identity is confirmed by mass spectrometry; and independent third-party laboratories corroborate in-house analytics to maintain traceable quality metrics appropriate for research use.

• Intended research use
FLGR242 is evaluated in controlled in-vitro systems that examine fibroblast-related signaling, cell–matrix interactions, and extracellular matrix assembly. All technical communications are method-centric and do not imply diagnostic, therapeutic, performance, or clinical outcomes.

• Research characteristics and applications
This peptide analog is characterized by a defined peptide sequence that models fibroblast-regulatory motifs involved in extracellular matrix assembly and cellular communication. In controlled in-vitro environments, it supports investigations into matrix protein organization, structural signaling cascades, and fibroblast-mediated remodeling mechanisms. Its reproducible performance and sequence fidelity make it suitable for research in cellular microenvironment modeling and biochemical pathway elucidation.

• Manufacturing and documentation
Alpha BioMed Labs manufactures this material in the United States under defined quality procedures and research-only labeling. COAs, raw-material provenance from vetted suppliers, and batch records are maintained to facilitate institutional procurement review and audit readiness.